Direct comparison between continuous and coseasonal regimen for sublingual immunotherapy in children with grass allergy: A randomized controlled study

Pediatric Allergy and Immunology

Volumn 22, Issue 8, 2011, Pages 803-807

  Pajno, Giovanni B ^a   Caminiti, Lucia ^a   Crisafulli, Giuseppe ^a   Vita, Daniela ^a   Valenzise, Mariella ^a   De Luca, Raffaele ^a   Passalacqua, Giovanni ^b  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Continuous regimen; Coseasonal regimen; Grass pollen; Respiratory allergy; Sublingual immunotherapy

Indexed keywords

DESLORATADINE; EYE DROPS; GRASS POLLEN EXTRACT; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G4; LEVOCABASTINE; NEDOCROMIL; PREDNISONE; SALBUTAMOL; STALORAL; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; ASTHMA; CHILD; DISEASE SEVERITY; DOSAGE SCHEDULE COMPARISON; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG USE; FEMALE; GRASS POLLEN; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; PARALLEL DESIGN; PHASE 4 CLINICAL TRIAL; POLLEN ALLERGY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINITIS; SCHOOL CHILD; SYMPTOM;

ADMINISTRATION, SUBLINGUAL; ADOLESCENT; ALLERGENS; ANTIGENS, PLANT; CHILD; CLINICAL PROTOCOLS; DESENSITIZATION, IMMUNOLOGIC; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; POACEAE; POLLEN; RHINITIS, ALLERGIC, SEASONAL; SEASONS;

EID: 82455212062     PISSN: 09056157     EISSN: 13993038     Source Type: Journal    
DOI: 10.1111/j.1399-3038.2011.01196.x     Document Type: Article

References (10)

1. Bousquet PJ, Durham SR, Cox L, et al. Sublingual immunotherapy: WAO Position Paper 2009. Canonica GW et al. edts. Allergy 2009: 64 (Suppl 91): 3-11.
2. Canonica GW, Passalacqua G. Disease modifying effect and economic implications of Sublingual immunotherapy. J Allergy Clin Immunol 2011: 127, 44-5.
3. Senna G, Ridolo E, Calderon M, Lombardi C, Canonica GW, Passalacqua G. Evidence of adherence to allergen-specific immunotherapy. Curr Opin Allergy Clin Immunol 2009: 9: 544-8.
4. Lombardi C, Incorvaia C, Braga M, Senna G, Canonica GW, Passalacqua G. Administration regimens for sublingual immunotherapy: what do we know. Allergy 2009: 64: 849-54.
5. Global Initiative on Asthma Management (GINA Guidelines). .
6. Dreborg S, Frew A. Position paper:allergen standardization and skin tests. Allergy 1993: 48 (Suppl.14): 49-82.
7. Canonica GW, Baena Cagnani C, Bousquet J, et al. Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce. Allergy 2007: 62: 317-24.
8. Durham SR, Emminger W, Kapp A, et al. Long-term clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet. J Allergy Clin Immunol 2010: 125: 131-8.
9. Calderon MA, Birk AO, Andersen JS, Durham SR. Prolonged preseasonal treatment phase with Grazax sublingual immunotherapy increases clinical efficacy. Allergy 2007: 62: 958-61.
10. Di Bona D, Plaia A, Scafidi V, Leto-Barone MS, Di Lorenzo G. Efficacy of sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: a systematic review and meta-analysis. J Allergy Clin Immunol 2010: 126: 558-66.